AVANIR INITIATES PHASE III CLINICAL TRIAL OF NEURODEX.

Extract


AVANIR INITIATES PHASE III CLINICAL TRIAL OF NEURODEX.

AVANIR Pharmaceuticals (AMEX:AVN), San Diego., has initiatiated a double-blind, placebo-controlled, multicenter, Phase III clinical trial of Neurodex(TM) in patients...

See the full content of this document

Sponsored links




ver las páginas en versión mobile | web

ver las páginas en versión mobile | web

© Copyright 2012, vLex. All Rights Reserved.

Contents in vLex United States

Explore vLex

For Professionals

For Partners

Company